Ernexa Therapeutics, Inc. (ERNA)
1.36
-0.27
(-16.56%)
USD |
NASDAQ |
Nov 20, 16:00
1.41
+0.05
(+3.68%)
After-Hours: 20:00
Ernexa Therapeutics Price to Book Value : 0.5143 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.5143 |
| November 19, 2026 | 0.6164 |
| November 18, 2026 | 0.6126 |
| November 17, 2026 | 0.6164 |
| November 16, 2026 | 0.6391 |
| November 13, 2026 | 0.6353 |
| November 12, 2026 | 0.6769 |
| November 11, 2026 | 0.7299 |
| November 10, 2026 | 0.7601 |
| November 09, 2026 | 0.7752 |
| November 06, 2026 | 0.7109 |
| November 05, 2026 | 0.692 |
| November 04, 2026 | 0.7525 |
| November 03, 2026 | 0.7639 |
| November 02, 2026 | 0.7374 |
| October 30, 2026 | 0.745 |
| October 29, 2026 | 0.7979 |
| October 28, 2026 | 0.7488 |
| October 27, 2026 | 0.7537 |
| October 26, 2026 | 0.7329 |
| October 23, 2026 | 0.7809 |
| October 22, 2026 | 0.7847 |
| October 21, 2026 | 0.7979 |
| October 20, 2026 | 0.8471 |
| October 19, 2026 | 0.7488 |
| Date | Value |
|---|---|
| October 16, 2026 | 0.7904 |
| October 15, 2026 | 0.8206 |
| October 14, 2026 | 0.7979 |
| October 13, 2026 | 0.8357 |
| October 12, 2026 | 0.8357 |
| October 09, 2026 | 0.9076 |
| October 08, 2026 | 0.9416 |
| October 07, 2026 | 0.9038 |
| October 06, 2026 | 0.8452 |
| October 05, 2026 | 1.021 |
| October 02, 2026 | 1.119 |
| October 01, 2026 | 1.119 |
| September 30, 2026 | 1.210 |
| September 29, 2026 | 1.156 |
| September 28, 2026 | 1.269 |
| September 25, 2026 | 1.26 |
| September 24, 2026 | 1.324 |
| September 23, 2026 | 1.335 |
| September 22, 2026 | 1.390 |
| September 21, 2026 | 1.448 |
| September 18, 2026 | 1.401 |
| September 17, 2026 | 1.375 |
| September 16, 2026 | 1.43 |
| September 15, 2026 | 1.492 |
| September 14, 2026 | 1.562 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cerenome, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
Price to Book Value Related Metrics
| Price | 1.36 |
| Earnings Yield | -1.25K% |
| Market Cap | 2.237M |